Welcome to IPE. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
  • IPE.com
  • IPE Real Assets
  • IPE Reference Hub
  • IPE Quest
  • Impact Investor
IPE
IPE May-June 2025 cover
Current Edition

IPE magazine May/June 2025

Search sponsor
Securities Tracker
IPE
Mast navigation
  • Sign In
Search our site
Menu
Close menu
  • Latest
    • Back to parent navigation item
    • Latest
    • News
    • Analysis
    • Comment
    • Topics
      • Back to parent navigation item
      • Topics
      • ESG
      • Regulation
      • Strategy
      • People moves
    • Topics A-Z
  • Countries
    • Back to parent navigation item
    • Countries
    • Austria
    • Belgium
    • CEE
    • EU
    • France
    • Germany
    • Ireland
    • Italy
    • Netherlands
    • Nordic region
    • Spain & Portugal
    • Switzerland
    • United Kingdom
    • A-Z of countries
  • Reports
    • Back to parent navigation item
    • Reports
    • Top 500 Asset Managers
    • Top 1000 Pension Funds
    • Asset Class Reports
    • Country Reports
    • Special Reports
  • Pension Funds
  • Investment
  • AI
  • Research
  • Events
    • Back to parent navigation item
    • Events
    • IPE Events 2025
    • IPE Conference & Awards 2025
    • IPE Webcasts 2025
  • Podcasts
  • Membership Options
  • IPE Real Assets
  • IPE Reference Hub
  • IPE Quest
  • Impact Investor
  • More from navigation items
  • Latest
      • News
      • Analysis
      • Comment
      • Topics
        • ESG
        • Regulation
        • Strategy
        • People moves
      • Topics A-Z
  • Countries
      • Austria
      • Belgium
      • CEE
      • EU
      • France
      • Germany
      • Ireland
      • Italy
      • Netherlands
      • Nordic region
      • Spain & Portugal
      • Switzerland
      • United Kingdom
      • A-Z of countries
  • Reports
      • Top 500 Asset Managers
      • Top 1000 Pension Funds
      • Asset Class Reports
      • Country Reports
      • Special Reports
    • Top 500 social 25 1
      IPE Top 500 Asset Managers: leading managers outpace the rest in a year of record AUM growth
    • ESG supplement IPE November 2024
      ESG: Investors embrace new challenges on 1.5°C climate goal
    • Top-1000-2024-900x613
      Top 1000 Pension Funds 2024: Pensions back at a sweet spot
  • Pension Funds
  • Investment
  • AI
  • Research
  • Events
      • IPE Events 2025
      • IPE Conference & Awards 2025
      • IPE Webcasts 2025
  • Podcasts
  • Membership Options

Search results

Your search for Sanofi found 39 results. Displaying results 1 to 20 | Search Help

Use the filters to refine the results. Or use quotation marks to search for an exact phrase - e.g. "pocket money". Or use NOT to reduce unwanted matches, e.g. Paris NOT Texas, will find matches for Paris, but exclude stories which also have the word Texas.
Filter search

Filters

Keyword

Filter your search

By Type

No selections available

By Topics

No selections available

By Asset Classes

No selections available

By Strategies

No selections available

By Countries & Regions

No selections available

By Magazine regulars

No selections available

By date

No selections available
  • Date range
  • Save article
    Please Sign in to your account to use this feature
    Sanofi Pension Scheme signs £1.4bn buy-in with Legal & General
    News

    Sanofi Pension Scheme signs £1.4bn buy-in with Legal & General

    28 January 2025

    All members of the scheme are now insured via buy-ins with Legal & General

  • Save article
    Please Sign in to your account to use this feature
    Sanofi UK pension scheme agrees £760m buy-in with L&G
    News

    Sanofi UK pension scheme agrees £760m buy-in with L&G

    12 October 2021

    First pension risk transfer with the insurer after being a long-term asset management client

  • Save article
    Please Sign in to your account to use this feature
    News

    Germany added to Sanofi pension fund in Belgium cross-border first

    4 October 2021

    ‘This will open doors for other multinational corporations,’ says Aon

  • Save article
    Please Sign in to your account to use this feature
    Fondaereo’s cross-border project could shake up landscape as EU reviews IORP II
    News

    Fondaereo’s cross-border project could shake up landscape as EU reviews IORP II

    23 August 2024

    IORP II directive has ‘complicated the regulatory landscape, says CBBA’s Francesco Briganti

  • Uncovering the qualities that set compounders apart
    White papers

    Uncovering the qualities that set compounders apart

    Reference Hub1 June 2024 By Comgest

    Compounder companies (“compounders”) are those with highly visible and long-duration growth. Lindy’s Law explains an anti-ageing process for such companies — the longer they exist, the stronger they become to survive well into the future. This enables many to become industry leaders and dominant global players. We refer to these types of venerable companies as “marathon runners”. They form the bedrock of the returns we generate for our clients. It’s not just their age that sets these companies apart. It’s the combination of unique corporate culture and resilience that keeps them growing in good and bad times.

  • A closer look at European equities
    White papers

    A closer look at European equities

    Reference Hub1 October 2024 By STOXX

    Interview with Arun Singhal, Global Head of Product Management at STOXX.

  • Save article
    Please Sign in to your account to use this feature
    News

    Cross-border IORPs down to 33 post-Brexit, says EIOPA in new report

    6 December 2021

    Supervisory authority publishes first in series of annual reports dedicated to cross-border pension funds

  • Save article
    Please Sign in to your account to use this feature
    Belgium: First-pillar reform caps highest pensions
    Special Report

    Belgium: First-pillar reform caps highest pensions

    Top 1000 Pension Funds 2023

    Federal government manages to work out a first-pillar agreement before the parliamentary recess  

  • Save article
    Please Sign in to your account to use this feature
    Wellcome says 34.5% returns will reinforce new strategy and raised ambitions
    News

    Wellcome says 34.5% returns will reinforce new strategy and raised ambitions

    11 January 2022

    The charity said the ‘exceptional’ performance for 2020/21 came largely from its private assets

  • Save article
    Please Sign in to your account to use this feature
    EIOPA names members of new pensions stakeholder group
    News

    EIOPA names members of new pensions stakeholder group

    9 July 2020

    PensionsEurope’s Leppälä and APG’s Steenbeek among returning, new IORP representatives

  • Save article
    Please Sign in to your account to use this feature
    Fixed Income – European investment grade: No sign of end for negative yields
    Asset Class Reports

    Fixed Income – European investment grade: No sign of end for negative yields

    January 2020 (Magazine)

    Negative interest rates look set for a lengthy run in Europe, raising concerns about the long-term effects

  • Save article
    Please Sign in to your account to use this feature
    Innovation is key for pharma
    Asset Class Reports

    Innovation is key for pharma

    April 2019 (Magazine)

    Europe’s pharmaceuticals sector must be innovative to stay ahead of global rivals

  • Save article
    Please Sign in to your account to use this feature
    News

    IPE Views: Can Europe win the dengue race?

    21 May 2015

    Joseph Mariathasan explores the impact of – and possible solution to – the growing dengue epidemic

  • Save article
    Please Sign in to your account to use this feature
    Asset Class Reports

    European pharma under threat

    April 2016 (Magazine)

    Pharmaceuticals have long been the foundation of Europe’s industrial base. Now the sector must fight back against the threat of US biotech companies

  • Save article
    Please Sign in to your account to use this feature
    Special Report

    SDG reporting: Beyond SDG-washing

    May 2021 (Magazine)

    Only thorough processes and due diligence can make sense of the welter of claims and frameworks by companies using the SDGs as a reporting tool

  • Pharmaceutical companies in a golden age for drug discovery
    Asset Manager News

    Pharmaceutical companies in a golden age for drug discovery

    Reference Hub15 May 2020 By Columbia Threadneedle Investments

    As new technologies such as genomics spur development of innovative drugs, European pharmaceuticals companies stand out as high-quality, defensive growth stocks

  • Save article
    Please Sign in to your account to use this feature
    Special Report

    Top 400 Asset Managers: Outcomes revolution in investment management and pharmaceuticals

    June 2013 (Magazine)

    Mitesh Sheth outlines what investment managers can learn from the transformation taking place in the pharmaceutical industry

  • Save article
    Please Sign in to your account to use this feature
    News

    Joseph Mariathasan: Europe’s pharmaceutical and biotech industries

    31 October 2016

    Europe’s pharmaceutical sector must find a way to emulate US biotech, Joseph Mariathasan writes

  • Save article
    Please Sign in to your account to use this feature
    Drug companies suffer from lack of sustainability, says oekom
    News

    Drug companies suffer from lack of sustainability, says oekom

    24 August 2011

    Pharmaceutical companies 'react rather than act', according to ratings agency.

  • Save article
    Please Sign in to your account to use this feature
    News

    Belgian pension funds return 1.45% over first half as Brexit hits hard

    18 October 2016

    National occupational pension association points to recovery after ‘very negative’ Brexit impact

  • Previous Page
  • 1
  • 2
  • Next Page
  • Contact us
  • Membership and subscriptions
  • Company overview
  • IPE media pack 2025
  • Advertising terms and conditions
  • Standard Terms and Conditions for Event Sponsors
  • Digital editions
IPE   FD Business

Copyright © 1997–2025 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP

  • Previous issues
  • Contributors A-Z
  • Subjects A-Z
  • Privacy policy
  • Cookie policy
  • Acceptable use policy
  • Terms & conditions
  • Manage my consent
  • B Corp™
  • Subscribe to IPE
  • Follow us on X
  • Join us on LinkedIn
  • B-Corp-Logo-Tagline-Lockup-Standards-White-RGB-300px

Site powered by Webvision Cloud